58539-11-0 Usage
General Description
Ethyl 3-bromo-2-(bromomethyl)propionate is a chemical compound with the molecular formula C6H10Br2O2. It is an organobromine compound that consists of a propionate group with two bromine atoms attached to the second carbon and a bromomethyl group attached to the third carbon. This chemical is commonly used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. It is also utilized in the production of other organic compounds and materials. Ethyl 3-bromo-2-(bromomethyl)propionate is a colorless to pale yellow liquid that has a distinctive smell and is soluble in organic solvents such as ethanol and acetone. However, it is not soluble in water. Ethyl 3-bromo-2-(bromomethyl)propionate is flammable and should be handled with caution in a controlled laboratory environment.
Check Digit Verification of cas no
The CAS Registry Mumber 58539-11-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,8,5,3 and 9 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 58539-11:
(7*5)+(6*8)+(5*5)+(4*3)+(3*9)+(2*1)+(1*1)=150
150 % 10 = 0
So 58539-11-0 is a valid CAS Registry Number.
InChI:InChI=1/C6H10Br2O2/c1-2-10-6(9)5(3-7)4-8/h5H,2-4H2,1H3
58539-11-0Relevant articles and documents
1,2-DITHIOLANE AND DITHIOL COMPOUNDS USEFUL IN TREATING MUTANT EGFR-MEDIATED DISEASES AND CONDITIONS
-
Paragraph 0326-0327, (2018/08/12)
Compositions of the invention comprise 1,2-dithiolane, dithiol and related compounds useful as therapeutic agents for the treatment and prevention of diseases and conditions associated with aberrant EGFR activity.
Salts of 3-azabicyclo [3.3.1]nonanes as antiarrhythmic agents, and precursors thereof
-
, (2008/06/13)
Salts of 3-azabicyclo[3.3.1]nonanes are used in controlling antiarrhythmic processes and precursors thereof are disclosed.
Methyl α-(bromomethyl)acrylate
Cassady, John M.,Howie, Gary A.,Robinson, J. Michael,Stamos, Ioannis K.
, p. 77 - 77 (2017/05/20)
-